
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 15.210 | 15.450 | 0.240 |
Bonds | 84.790 | 84.790 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 100.806 | 17.316 |
Price to Book | 7.250 | 2.200 |
Price to Sales | 3.525 | 1.545 |
Price to Cash Flow | - | 9.702 |
Dividend Yield | - | 2.778 |
5 Years Earnings Growth | - | 11.030 |
Name | Net % | Category Average |
---|---|---|
Government | 57.784 | 32.946 |
Corporate | 22.145 | 48.162 |
Securitized | 10.783 | 6.779 |
Cash | 8.494 | 15.607 |
Derivative | 0.794 | 11.812 |
Number of long holdings: 119
Number of short holdings: 3
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Bundei 0,5% Ap30 Eur | DE0001030559 | 4.46 | 100.11 | -0.29% | |
Obligacionesei 1% Nv30 Eur | ES00000127C8 | 3.35 | 100.29 | -1.09% | |
Finland 1.375 15-Apr-2027 | FI4000527551 | 2.75 | 99.150 | -0.13% | |
Belgium Tf 0,8% Gn27 Eur | BE0000341504 | 2.56 | 97.69 | -0.11% | |
Rheinland-Pfalz (Land) 2.375% | DE000RLP1593 | 2.45 | - | - | |
GlaxoSmithKline Capital PLC 4% | XS0222383027 | 1.93 | - | - | |
Germany (Federal Republic Of) 1.7% | DE000BU22098 | 1.73 | - | - | |
European Union 0% | EU000A3L6N78 | 1.73 | - | - | |
Austria Tf 0,75% Ot26 Eur | AT0000A1K9C8 | 1.71 | 98.69 | +0.09% | |
European Union 0% | EU000A4D85N4 | 1.70 | - | - |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Flossbach von Storch Bond Opportuni | 6.19B | 1.61 | 3.02 | 3.16 | ||
Flossbach von Storch Bond Opportune | 6.19B | 1.40 | 2.50 | 2.64 | ||
LU1481584016 | 6.18B | 1.61 | 3.02 | 3.16 | ||
LU1481583711 | 6.18B | 1.40 | 2.50 | 2.64 | ||
LU1748855837 | 6.18B | 1.52 | 2.81 | - |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review